08 Sep 2022 Governance
Statement from Leukaemia UK on the death of Her Majesty Queen Elizabeth II
On behalf of the Leukaemia UK team, Chair of Trustees, Chris Corbin OBE, has made the following statement:
“We are extremely saddened to hear the news of the death of Her Majesty Queen Elizabeth II. 
Together with the nation and people around the world, we remember a true leader who gave her life to duty. The Queen’s dedication, diligence and integrity were an inspiration to all and we are thankful for an inspiring monarch, who gave her life in service of her country and the Commonwealth.
The Queen’s support for the charity sector has enabled charities in the UK to thrive during her reign and will have a lasting impact for those whom the charities support.
We share our condolences with the entire Royal Family and especially the Queen’s children and grandchildren. Our thoughts are with them at this very difficult time.”
Related posts
18 September 2025
1 in 4 leukaemia patients in England experiences an avoidable delay in diagnosis
A first of its kind study, commissioned by Leukaemia UK, has revealed that a quarter (26%) of leukaemia patients in England experience avoidable delays in their diagnosis, resulting in a…
2 October 2023
Three leading charities collaborate to fight childhood cancers
New Partnership we3can to fund research into three most common childhood cancers Today (2nd October 2023), three leading cancer charities have launched a new collaboration in order to improve the…
15 February 2024
Vogue model who survived leukaemia as a child joins Leukaemia UK in calling for more donations for research to stop blood cancer ‘destroying childhoods’
Vogue model Saffron Vadher has joined Leukaemia UK on International Childhood Cancer Day (February 15th) in calling for more research into the blood cancer. Leukaemia is the most common type…
23 October 2024
Leukaemia UK announces innovative projects by four female researchers addressing aggressive blood cancers
Leukaemia UK has today announced it will invest £600,000 into four groundbreaking research projects aimed at developing kinder, more effective treatments for various aggressive blood cancers, including acute myeloid leukaemia…